APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tecentriq

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tecentriq Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchTecentriq Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Tecentriq Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Tecentriq Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tecentriq Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Tecentriq Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Tecentriq market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tecentriq is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tecentriq is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tecentriq is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tecentriq market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tecentriq market include Roche. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tecentriq market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tecentriq and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tecentriq sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tecentriq market size, projected growth trends, production technologies, key applications, and end-use industries.

Tecentriq Segment by Company

Roche

Tecentriq Segment by Type

60mg/ml

Other

Tecentriq Segment by Application

Small Cell Lung Cancer

Triple-Negative Breast Cancer (TNBC)

Urothelial Carcinoma

Non-Small Cell Lung Cancer (NSCLC)

Tecentriq Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tecentriq status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tecentriq market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tecentriq significant trends, drivers, influence factors in global and regions.

6. To analyze Tecentriq competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tecentriq market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tecentriq and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tecentriq.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tecentriq market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tecentriq industry.

Chapter 3: Detailed analysis of Tecentriq manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tecentriq in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tecentriq in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tecentriq Industry Trends Table 2. Tecentriq Industry Drivers Table 3. Tecentriq Industry Opportunities and Challenges Table 4. Tecentriq Industry Restraints Table 5. Global Tecentriq Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tecentriq Revenue Share by Company (2021-2026) Table 7. Global Tecentriq Sales Volume by Company (tons) & (2021-2026) Table 8. Global Tecentriq Sales Volume Share by Company (2021-2026) Table 9. Global Tecentriq Average Price (US$/ton) of Company (2021-2026) Table 10. Global Tecentriq Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tecentriq Key Company Manufacturing Base & Headquarters Table 12. Global Tecentriq Company, Product Type & Application Table 13. Global Tecentriq Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tecentriq by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 60mg/ml Table 18. Significant Companies of Other Table 19. Global Tecentriq Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Tecentriq Sales Volume by Type (2021-2026) & (tons) Table 21. Global Tecentriq Sales Volume by Type (2027-2032) & (tons) Table 22. Global Tecentriq Sales Volume Share by Type (2021-2026) Table 23. Global Tecentriq Sales Volume Share by Type (2027-2032) Table 24. Global Tecentriq Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tecentriq Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Tecentriq Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Tecentriq Sales Value Share by Type (2021-2026) Table 28. Global Tecentriq Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Small Cell Lung Cancer Table 30. Significant Companies of Triple-Negative Breast Cancer (TNBC) Table 31. Significant Companies of Urothelial Carcinoma Table 32. Significant Companies of Non-Small Cell Lung Cancer (NSCLC) Table 33. Global Tecentriq Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 34. Global Tecentriq Sales Volume by Application (2021-2026) & (tons) Table 35. Global Tecentriq Sales Volume by Application (2027-2032) & (tons) Table 36. Global Tecentriq Sales Volume Share by Application (2021-2026) Table 37. Global Tecentriq Sales Volume Share by Application (2027-2032) Table 38. Global Tecentriq Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Tecentriq Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Tecentriq Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Tecentriq Sales Value Share by Application (2021-2026) Table 42. Global Tecentriq Sales Value Share by Application (2027-2032) Table 43. Global Tecentriq Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 44. Global Tecentriq Sales by Region (2021-2026) & (tons) Table 45. Global Tecentriq Sales Market Share by Region (2021-2026) Table 46. Global Tecentriq Sales by Region (2027-2032) & (tons) Table 47. Global Tecentriq Sales Market Share by Region (2027-2032) Table 48. Global Tecentriq Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Tecentriq Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Tecentriq Sales Value Share by Region (2021-2026) Table 51. Global Tecentriq Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Tecentriq Sales Value Share by Region (2027-2032) Table 53. Global Tecentriq Market Average Price (US$/ton) by Region (2021-2026) Table 54. Global Tecentriq Market Average Price (US$/ton) by Region (2027-2032) Table 55. Global Tecentriq Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 56. Global Tecentriq Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Tecentriq Sales by Country (2021-2026) & (tons) Table 58. Global Tecentriq Sales Market Share by Country (2021-2026) Table 59. Global Tecentriq Sales by Country (2027-2032) & (tons) Table 60. Global Tecentriq Sales Market Share by Country (2027-2032) Table 61. Global Tecentriq Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Tecentriq Sales Value Market Share by Country (2021-2026) Table 63. Global Tecentriq Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Tecentriq Sales Value Market Share by Country (2027-2032) Table 65. Roche Company Information Table 66. Roche Business Overview Table 67. Roche Tecentriq Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Roche Tecentriq Product Portfolio Table 69. Roche Recent Development Table 70. Key Raw Materials Table 71. Raw Materials Key Suppliers Table 72. Tecentriq Distributors List Table 73. Tecentriq Customers List Table 74. Research Programs/Design for This Report Table 75. Authors List of This Report Table 76. Secondary Sources Table 77. Primary Sources List of Figures Figure 1. Tecentriq Product Image Figure 2. Global Tecentriq Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tecentriq Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tecentriq Sales (2021-2032) & (tons) Figure 5. Global Tecentriq Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Tecentriq Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 60mg/ml Image Figure 10. Other Image Figure 11. Global Tecentriq Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Tecentriq Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Tecentriq Sales Volume Share by Type (2021-2032) Figure 14. Global Tecentriq Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Tecentriq Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Tecentriq Sales Value Share by Type (2021-2032) Figure 17. Small Cell Lung Cancer Image Figure 18. Triple-Negative Breast Cancer (TNBC) Image Figure 19. Urothelial Carcinoma Image Figure 20. Non-Small Cell Lung Cancer (NSCLC) Image Figure 21. Global Tecentriq Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 22. Global Tecentriq Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Tecentriq Sales Volume Share by Application (2021-2032) Figure 24. Global Tecentriq Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Tecentriq Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Tecentriq Sales Value Share by Application (2021-2032) Figure 27. Global Tecentriq Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 28. Global Tecentriq Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Tecentriq Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Tecentriq Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Tecentriq Sales Value (2021-2032) & (US$ Million) Figure 32. North America Tecentriq Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Tecentriq Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Tecentriq Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Tecentriq Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Tecentriq Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Tecentriq Sales Value (2021-2032) & (US$ Million) Figure 38. South America Tecentriq Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Tecentriq Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Tecentriq Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Tecentriq Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Tecentriq Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Tecentriq Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Tecentriq Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Tecentriq Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 60mg/ml
  • Other
Applications
  • Small Cell Lung Cancer
  • Triple-Negative Breast Cancer (TNBC)
  • Urothelial Carcinoma
  • Non-Small Cell Lung Cancer (NSCLC)
Companies covered
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tecentriq Sales Value (2021-2032)
  4. 1.2.2 Global Tecentriq Sales Volume (2021-2032)
  5. 1.2.3 Global Tecentriq Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tecentriq Market Dynamics
  1. 2.1 Tecentriq Industry Trends
  2. 2.2 Tecentriq Industry Drivers
  3. 2.3 Tecentriq Industry Opportunities and Challenges
  4. 2.4 Tecentriq Industry Restraints
3 Tecentriq Market by Company
  1. 3.1 Global Tecentriq Company Revenue Ranking in 2025
  2. 3.2 Global Tecentriq Revenue by Company (2021-2026)
  3. 3.3 Global Tecentriq Sales Volume by Company (2021-2026)
  4. 3.4 Global Tecentriq Average Price by Company (2021-2026)
  5. 3.5 Global Tecentriq Company Ranking (2024-2026)
  6. 3.6 Global Tecentriq Company Manufacturing Base and Headquarters
  7. 3.7 Global Tecentriq Company Product Type and Application
  8. 3.8 Global Tecentriq Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tecentriq Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tecentriq Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tecentriq Market by Type
  1. 4.1 Tecentriq Type Introduction
  2. 4.1.1 60mg/ml
  3. 4.1.2 Other
  4. 4.2 Global Tecentriq Sales Volume by Type
  5. 4.2.1 Global Tecentriq Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tecentriq Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Tecentriq Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Tecentriq Sales Value by Type
  9. 4.3.1 Global Tecentriq Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tecentriq Sales Value by Type (2021-2032)
  11. 4.3.3 Global Tecentriq Sales Value Share by Type (2021-2032)
5 Tecentriq Market by Application
  1. 5.1 Tecentriq Application Introduction
  2. 5.1.1 Small Cell Lung Cancer
  3. 5.1.2 Triple-Negative Breast Cancer (TNBC)
  4. 5.1.3 Urothelial Carcinoma
  5. 5.1.4 Non-Small Cell Lung Cancer (NSCLC)
  6. 5.2 Global Tecentriq Sales Volume by Application
  7. 5.2.1 Global Tecentriq Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tecentriq Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Tecentriq Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Tecentriq Sales Value by Application
  11. 5.3.1 Global Tecentriq Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tecentriq Sales Value by Application (2021-2032)
  13. 5.3.3 Global Tecentriq Sales Value Share by Application (2021-2032)
6 Tecentriq Regional Sales and Value Analysis
  1. 6.1 Global Tecentriq Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tecentriq Sales by Region (2021-2032)
  3. 6.2.1 Global Tecentriq Sales by Region: 2021-2026
  4. 6.2.2 Global Tecentriq Sales by Region (2027-2032)
  5. 6.3 Global Tecentriq Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tecentriq Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tecentriq Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tecentriq Sales Value by Region (2027-2032)
  9. 6.5 Global Tecentriq Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tecentriq Sales Value (2021-2032)
  12. 6.6.2 North America Tecentriq Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tecentriq Sales Value (2021-2032)
  15. 6.7.2 Europe Tecentriq Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tecentriq Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tecentriq Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tecentriq Sales Value (2021-2032)
  21. 6.9.2 South America Tecentriq Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tecentriq Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tecentriq Sales Value Share by Country, 2025 VS 2032
7 Tecentriq Country-level Sales and Value Analysis
  1. 7.1 Global Tecentriq Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tecentriq Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tecentriq Sales by Country (2021-2032)
  4. 7.3.1 Global Tecentriq Sales by Country (2021-2026)
  5. 7.3.2 Global Tecentriq Sales by Country (2027-2032)
  6. 7.4 Global Tecentriq Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tecentriq Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tecentriq Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tecentriq Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tecentriq Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tecentriq Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tecentriq Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tecentriq Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tecentriq Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tecentriq Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tecentriq Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tecentriq Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tecentriq Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tecentriq Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tecentriq Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tecentriq Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tecentriq Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tecentriq Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tecentriq Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tecentriq Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tecentriq Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tecentriq Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tecentriq Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tecentriq Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tecentriq Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tecentriq Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tecentriq Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tecentriq Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tecentriq Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tecentriq Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tecentriq Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tecentriq Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tecentriq Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tecentriq Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tecentriq Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tecentriq Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tecentriq Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tecentriq Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tecentriq Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tecentriq Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tecentriq Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tecentriq Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tecentriq Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tecentriq Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tecentriq Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tecentriq Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tecentriq Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tecentriq Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tecentriq Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tecentriq Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tecentriq Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tecentriq Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tecentriq Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tecentriq Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tecentriq Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tecentriq Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tecentriq Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tecentriq Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tecentriq Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tecentriq Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tecentriq Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tecentriq Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tecentriq Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tecentriq Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tecentriq Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tecentriq Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tecentriq Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tecentriq Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tecentriq Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tecentriq Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tecentriq Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tecentriq Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tecentriq Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tecentriq Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tecentriq Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tecentriq Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tecentriq Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tecentriq Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tecentriq Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tecentriq Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tecentriq Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tecentriq Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tecentriq Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tecentriq Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tecentriq Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tecentriq Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tecentriq Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Tecentriq Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Tecentriq Product Portfolio
  6. 8.1.5 Roche Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tecentriq Value Chain Analysis
  2. 9.1.1 Tecentriq Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tecentriq Sales Mode & Process
  6. 9.2 Tecentriq Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tecentriq Distributors
  9. 9.2.3 Tecentriq Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst